The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing pre-exposure prophylaxis regimens in MSM
2019
Objective:HIV Prevention Trials Network 069/AIDS Clinical Trials Group A5305 was a study of 48-week oral
pre-exposure prophylaxis(PrEP) regimens in MSM and
transgenderwomen. A rectal substudy was included to evaluate drug concentrations in rectal compartment vs. blood, gut-associated lymphoid tiss
Keywords:
-
Correction
-
Source
-
Cite
-
Save
41
References
9
Citations
NaN
KQI